Supplementing SARS-CoV-2 genomic surveillance with PCR-based variant detection for real-time actionable information, the Netherlands, June to July 2021

R. Molenkamp*, E. Fanoy, L. Derickx, T. de Groot, M. Jonges, T. Leenstra, R. Nijhuis, S. Pas, A. Vahidnia, C. von Wintersdorff, B. Mulder, M. Koopmans

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

We evaluated routine testing with SARS-CoV-2 Delta variant-specific RT-PCR in regional hospital laboratories in addition to centralised national genomic surveillance in the Netherlands during June and July 2021. The increase of the Delta variant detected by RT-PCR correlated well with data from genomic surveillance and was available ca 2 weeks earlier. This rapid identification of the relative abundance and increase of SARS-CoV-2 variants of concern may have important benefits for implementation of local public health measures.
Original languageEnglish
Article number2100921
Number of pages4
JournalEurosurveillance
Volume26
Issue number40
DOIs
Publication statusPublished - 7 Oct 2021

Cite this